World Health Summit 2011

October 23-26, 2011


In medicine time can make all the difference between life and death. Obviously in emergen-cies every second counts. In research, however, developing new and effective approaches to combating disease is bound to take some time. But even here it is clear that the faster new scientific findings translate into practical applications, the sooner suffering can be relieved and lives saved. So in research, too, every day counts.

Cooperation is a crucial way of saving valuable time. In Germany we are establishing new research centres for six common diseases that will allow us to pool expertise and speed up the process of translating research results into standard treatments. In the treatment of neglected diseases and the diseases of poverty, too, cooperation is key to achieving rapid progress. Only if researchers, policy-makers, business and civil society work together at international level can we expect solutions that really work.

Cooperation needs mutual trust and understanding. I am therefore delighted that the World Health Summit in Berlin has proved to be an ideal venue for international dialogue in this field. The motto of this year’s conference, “today’s evidence science – tomorrow’s agenda”, high¬lights the seminal role of research in achieving medical advances. It reminds us, too, that shared insights and responsibility must be followed by prompt action.

I wish the World Health Summit 2011 participants and organizers a very productive confer-ence and a host of stimulating discussions and encounters.

Angela Merkel
Chancellor of the Federal Republic of Germany

Health is the major topic of the 21st century. The increase of chronic diseases in every part of the world, together with changing demographics, imposes tough challenges on our health systems. The shift to a more personalized medicine brings along great opportunities but also sincere questions of feasibility which we need to solve. This requires true collaboration and close links between governments, researchers and industry, between public and private sectors. Financial constraints force us to increase efficiency and reduce costs but not the quality of health care. This requires less bureaucracy for more action.

Eleven years ago, the world committed itself to the Millennium Developmental Goals: reduce extreme poverty, increase education, decrease child mortality, improve maternal health, and reduce infectious diseases. We still have a considerable way ahead of us. The financial crisis has left its severe marks in rich countries while it costs lives in the poorest ones. We need innovative financing models and new governance structures to sustain the financial engagements of the rich countries for the poor. Our structures have to adapt to the health challenges of the 21st century.

The World Health Summit being held at the Charité in Berlin has become the foremost global meeting of its kind to convene leaders from academia, economy, industry, governments, international organizations and civil society around the pressing health issues of our time. It also contributes to promote the work fulfilled by the M8 Alliance which brings together eight major faculties of medicine throughout the world.

I wish all the best for the 3rd edition of the World Health Summit.

Nicolas Sarkozy
President of the French Republic


Today’s Science

We are living in an extraordinary period of history. Never before has the world experienced such progress in research and technology development, not only to fight diseases but also to prevent them, improving the quality of life worldwide. At the same time, our world is experiencing tough challenges: the rapid increase of non-communicable diseases and mental illness in addition to the still raging epidemics of HIV, TB and malaria strongly influence today’s health care and research agendas. Nearly 8 million children and pregnant women die every year as a consequence of preventable causes. The health effects of climate change are already being felt as the warming of the planet directly influences the distribution of food and water, but also of vector-borne diseases. What are effective strategies to adapt our research agendas to these increasing challenges? How can different stakeholder groups improve collaboration on an international scale to speed up and develop joint solutions?

· Response to Global Emerging Infectious Outbreaks
· No Health without Mental Health
· Adolescent Health - Its promise and potential

Research and Innovation

Medical advances arise from collaboration and mutual understanding between academia and health care providers, politicians and the private sector. The academic community is aware of its responsibility to deliver results based on a strong collaborative approach to improve global health. This comprises basic and preclinical research and the development of new therapies, but also increasingly the delivery of health services. The burning medical questions and health issues of our time need scientific answers without delay. How can we reorganize the academic system to increase translational efficiency between academic medicine, industry and others who are responsible for health care delivery? Effective incentives are needed for the development of “vulnerable” drug classes, e.g. antibiotics and of medical innovations for diseases of global health importance. What mechanisms do we need and how can the innovation process be accelerated? How can we realize adequate adaption of therapeutics to fit local conditions? What mechanisms and collaboration models do we need to tackle the health threat caused by counterfeit drugs?

· Bridging Health Gaps with Vaccines
· Innovation for Diseases of Global Health Importance
· Product Development for Neglected Patients

Strengthening Health Systems

Strong health systems are the basis of all development. Governments around the world are struggling with the challenges of providing good-quality healthcare under conditions of increasing financial constraints. Evidence on which to base sound rational decisions is in short supply. Critical shortages, an inadequate skill-mix and an uneven geographical distribution of the health workforce pose major barriers to achieving the health-related Millennium Development Goals (MDGs). The essential prerequisites of good health systems are a solid basis of public health education and adequate training of the health work-force. Information and communication technologies offer exciting innovative tools for many healthcare sectors. In addition, society and the media have to take much greater responsibility for the promotion of health and the prevention of diseases.

· Global Health Workforce Crisis
· The Future of Medical Education in a Globalized World
· Promoting Health, Preventing NCD

Tomorrow’s Agenda

Good health governance has always been of the utmost importance. However, evidence in this field is still weak. No country has yet discovered an ideal health-service model. Therefore the links between evidence and policy on all levels (national and international) need to be strengthened. How must innovative models of effective health collaboration and surveillance systems be shaped to tackle global challenges such as the increase of chronic diseases or the health consequences of global warming and degraded environment and urbanization? How can we control the various structural, socio-cultural and economic determinants of health? These are some of the important topics on tomorrow´s agenda.

· Evidence to Policy Linkages
· Strengthening National Governance of Research for Health
· Ensuring Public Health in Times of Climate Change

Karl Addicks
Physician, Former Member of the German Bundestag, Germany

Alvar Agusti
Director, University of Barcelona, Spain

Dora Nkem Akunyili
General Director, National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria

Paul Aliu
Global Program Team Director, Novartis, Switzerland

Ala Alwan
General Director, World Health Organization, Switzerland

Boris Azais
Director Policy Affairs, MSD, France

Brendan Barnes
Director, Health Policy and Corporate Responsibility, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium

Marie Bashir
Governor of New South Wales, Australia

Jorge Baxter
Director of Global Education and Outreach, Sesame Foundation, USA

Delphine Bazalgette
Country Representative, PlaNet Finance Deutschland e.V., Germany

Shalini Bharat
Chairperson of the Centre for Health and Social Sciences, Tata Institute of Social Sciences, School of Health Systems Studies, India

Mark Blecher
National Treasury, South Africa

Francois Bompart
Vice-President, Deputy Head and Medical Director Access to Medicines, Sanofi, France

Edward Bouwer
Professor, Johns Hopkins Bloomberg School of Public Health, USA

Nigel Bruce
Reader in Public Health, World Health Organization and Liverpool School of Tropical Medicine, UK

Reinhard Burger
President, Robert-Koch-Institute, Germany

Giovanni Cerri
Secretary of Health, Department of Health, State of Sao Paulo, Brazil

James Chau
TV Presenter, CCTV News, China

Rethy Chhem
Director, Section of Nuclear Medicine, Division of Human Health, International Atomic Energy Agency, Austria

Mickey Chopra
Chief of Health and Associate Director of Programmes, UNICEF, USA

John Clark
Pfizer GmbH, Germany

Pamela Collins
Director, Office for Research on Disparities and Global Mental Health, National Institute of Mental Health, USA

Nigel Crisp
Former Head of The Royal Liverpool and Broadgreen University Hospitals NHS Trust, UK

David de Kretser
Monash University, Faculty of Medicine, Nursing and Health Sciences, Australia

Nicoletta Dentico
Co-Director, Health Innovation for People (HIP), Australia

Philippe Douste-Blazy
Director, UNITAID, France

Mark Dybul
Co-Director, Global Health Law Program, Georgetown University, USA

Karl Max Einhäupl
CEO, Charité Universitätsmedizin Berlin, Germany

Christopher J. Elias
President and CEO, PATH, USA

David B. Evans
Director, World Health Organization, Switzerland

Antoine Flahault
Director and President, EHESP and ASPHER, France

Jean-Marc Fleury
Project Director and WFSJ Executive Director, World Federation of Science Journalists, Canada

Bronwyn Fredericks
Senior Research Fellow, Monash University, Australia

Howard Frumkin
Dean of the School of Public Health, University of Washington, USA

Shunichi Fukuhara
Director, Department of Epidemiology and Healthcare Research, Kyoto University School of Medicine and Public Health, Japan

Detlev Ganten
Co-President World Health Summit, Charité Universitätsmedizin Berlin, Germany

Patricia Garcia
Director of the Unit of Epidemiology, STI and HIV, Universidad Peruana Cayetano Heredia, Peru

Stefan German
Director for Partnerships and Research, World Vision International, Switzerland

Gerd Gigerenzer
Director, Harding Center for Risk Competence, Max-Planck-Institute, Germany

Jean-François Girard
President, Sorbonne Paris Cité, France

Marius Greuèl
Director, Pflegewerk Berlin, Germany

Joanna Groves
CEO, International Alliance of Patients' Organizations, UK

Annette Grüters-Kieslich
Dean, Charité Universitätsmedizin Berlin, Germany

Debbie Guha-Sapir
Director, Université Catholique de Louvain, WHO Collaborating Centre for Research on the Epidemiology of Disasters (CRED), Belgium

Sergio Guillèn
CEO, TSB Technologies for Health and Well-being, Spain

Nyaradzahi Gumbonzvanda
General Secretary, World Young Women's Christian Association, Switzerland

Thuy Huong Ha
Director Pharmaceutical Management Unit, Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland

Mareike Haase
Global Health Advocacy Officer, terre des hommes Deutschland e.V./ Action for Global Health, Germany

Andrew Haines
Director, London School of Hygiene and Tropical Medicine, UK

Victoria Hale
CEO, Medicines360, USA

Peter Hammann
R&D TSU Infectious Disease, Head External Opportunities and Innovation, Sanofi, Germany

Sheikh Hasina
Prime Minister, Bangladesh Government, Bangladesh

Robert Hecht
Principal and Managing Director, Results for Development Institute, UK

Dagfinn Høybråten
Chair of the Board, GAVI Alliance, Switzerland

Frika Chia Iskandar
Coordinator, Woman Working Group, Asia Pacific Network of People Living with HIV and AIDS (APN+), Thailand

Zsuzsanna Jakab
Director European Regional Office, World Health Organization, Denmark

W. Philip T. James
Hon. Professor of Nutrition, London School of Hygiene and Tropical Medicine, UK

Dean Jamison
University of Washington, USA

Jean Jannin
Coordinator, World Health Organization, Switzerland

Klaus Juffernbruch
Director, Connected Health, Cisco Systems GmbH, Germany

Jorge Kalil
Director, Instituto do Coracao AC, FMUSP, Brazil

Unni Karunakara
President of the International Council, Doctors Without Borders, Switzerland

Elly Katabira
Associate Professor of Medicine, Makerere Medical School, Uganda

Stefan Kaufmann
Director, Max-Planck Institute for Infection Biology, Germany

Michel Kazatchkine
Executive Director, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland

Ilona Kickbusch
Director, Global Health Programme, The Graduate Institute, Geneva, and Chair, Global Health Europe, Switzerland

Marie-Paule Kieny
Assistant Director General, World Health Organization, Switzerland

Michael J. Klag
Dean, Johns Hopkins Bloomberg School of Public Health, USA

Sabine Kleinert
Senior Executive Editor, The Lancet, UK

Friedrich Köhler
Director, Center for Cardiovascular Telemedicine, Charité - Universitätsmedizin Berlin, Germany

Eduardo Krieger
Brazilian Academy of Sciences and FMUSP, Brazil

Rudo Kwaramba
National Director, World Vision, Uganda

Jostacio Lapitan
Technical Officer, World Health Organization, Japan

Melanie Leitner
Chief Operating Officer, Chief Scientific Officer, Prize4Life, USA

Catherine Leport
Mission Pandemic Infectuous and Tropical Diseases, University Paris Diderot, France

James Love
Director, Knowledge Ecology International, USA

Anthony McMichael
Professor of Population Health, The Australian National University, Australia

Bettina Menne
Programme Manager Climate Change, Green Health Services and Sustainable Development, World Health Organization, Italy

Angela Merianos
Project Lead, Risk Assessment and Decision Support, World Health Organization, Switzerland

Philippe Meyer
Board Member, Genshagen Foundation, France

Suzie Miller
Monash University, Australia

Christina Mitchell
Dean, Monash University, Faculty of Medicine, Nursing and Health Sciences, Australia

Jürgen Mlynek
President, Helmholtz Association, Germany

Matshidiso Moeti
Assistant Regional Director, WHO, Regional Office for Africa (WHO / AFRO), Botswana

Themba Moeti
Managing Director, African Comprehensive HIV/AIDS Partnerships (ACHAP), Botswana

Joachim Müller-Jung
Head of the Department of Nature and Science, Frankfurter Allgemeine Zeitung, Germany

Maria Neira
Director, World Health Organization, Switzerland

Emmanuel Yuniwo Nfor
Senior Advisor, Supply Chain Management and Strategic Support, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland

Alexander Nies
Head, Department IG II Environment and Health, Chemical Safety, Federal Ministry for the Environment, Nature Conservation and Nuclear Safety, Germany

Violet Otindo
Media for Environment, Science, Health and Agriculture (MESHA), Kenya

Tikki Pang
Director, World Health Organization, Switzerland

Bernard Pécoul
Executive Director, Drugs for Neglected Diseases Initiative (DNDI), Switzerland

Roger Peng
Associate Professor, Johns Hopkins Bloomberg School of Public Health, USA

Christian Pfleiderer
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, Germany

Martin Prince
Professor of Epidemiological Psychiatry, King's College London, UK

Hugh Pullen
Associate Director External Trade and Product Integrity, S.A. Eli Lilly Benelux N.V., Belgium

Atif Rahman
Professor of Child Psychiatry, University of Liverpool, UK

Rino Rappuoli
Global Head of Vaccines Research, Novartis, Italy

Hoda Rashad
Director and Research Professor, Social Research Center, American University in Cairo, Egypt

Scott Ratzan
Vice President, Global Health, Government Affairs and Policy, Johnson&Johnson, USA

Olivier Raynaud
Senior Director, World Economic Forum, Switzerland

Ulrika Rehnstrom
United Nations Population Fund UNFPA, Sudan

Hermann Requardt
Sector CEO Healthcare, Siemens, Germany

Heinz Riederer
Executive Board, Sanofi, Germany

Ernst Rietschel
Steering Committee Representative, acatech - National Academy of Science and Engineering, Germany

Matthias Rompel
Director, Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ), Germany

Karin Roth
Member of the German Parliament, Germany

Nabil Safrany
European Commission, DG SANCO, Belgium

Dirk Sander
Consultant, Department Structural Prevention, Deutsche AIDS-Hilfe e.V., Germany

Shekhar Saxena
Director, World Health Organization, Mental Health and Substance Abuse Department, Switzerland

Hans-Joachim Schellnhuber
Director, Potsdam Institute for Climate Impact Research (PIK), Germany

Bernhard Schwartländer
Director, Evidence, Strategy and Results Department, UNAIDS, Switzerland

Robert Sebbag
Vice President Access to Medicines, Sanofi, France

Soraya Seedat
Professor of Psychiatry, Stellenbosch University, South Africa

Marylou Selo
President, Werner A. Selo Foundation, New York, USA

Michel Setbon
Ecole des Hautes Etudes en Santé Publique (EHESP), France

Martin Seychell
Deputy Director General for Consumers and Health, European Commission, Belgium

Mubashar Sheikh
Executive Director, Global Health Workforce Alliance, World Health Organization, Switzerland

Olive Shisana
CEO, South African Human Sciences Research Council, South Africa

Jae Hoon Song
Director, Samsung International Hospital Project, Korea

Agnes Soucat
Director, African Development Bank, Tunisia

Marc Sprenger
Director, European Centre of Disease Prevention and Control (ECDC), Sweden

Bruno Strigini
President of Europe/Canada, MSD, United Kingdom

Michael Strübin
Programme Manager, Europe, Continua Health Alliance, Belgium

Ellen t'Hoen
Executive Director, Medicines Patent Pool, Switzerland

Keizo Takemi
Senior Fellow, Global Health and Human Security, Japan Center for International Exchange, Japan

Yot Teerawatananon
Director of the Health Intervention and Technology Assessment Program, Ministry of Health, Thailand

H. E. Peter Tesch
Ambassador of Australia in Berlin, Germany

James Tielsch
Professor, Johns Hopkins Bloomberg School of Public Health, USA

Tido von Schön-Angerer
Director, Doctors Without Borders, Switzerland

Jane Waterman
CEO, International AIDS Vaccine Initiative (IAVI), The Netherlands

Günther Wess
CEO and President, Helmholtz Association, Germany

Annette Widmann-Mauz
State Secretary, Ministry of Health, Germany

Ulf Wiinberg
President and CEO, H. Lundbeck A/S, Denmark

John Wong
Dean at the Yong Loo School of Medicine, National University of Singapore, Singapore

Klaus Wowereit
Governing Mayor of Berlin, Germany

Shunichi Yamashita
Vice President, Fukushima Medical University, Japan

Anette-Gabrielle Ziegler
Director, Insitute of Diabetes Research, Helmholtz Association, Germany